Close Menu
StreamLineCrypto.comStreamLineCrypto.com
  • Home
  • Crypto News
  • Bitcoin
  • Altcoins
  • NFT
  • Defi
  • Blockchain
  • Metaverse
  • Regulations
  • Trading
What's Hot

Von der Nische zur Wall Street – Ripple erreicht das große Parkett beim Swell2025

November 10, 2025

Propanc Biopharma Secures up to $100 million for Crypto Treasury

November 10, 2025

BNY Sees Stablecoins, Tokenized Cash Hitting $3.6T by 2030

November 10, 2025
Facebook X (Twitter) Instagram
Tuesday, November 11 2025
  • Contact Us
  • Privacy Policy
  • Cookie Privacy Policy
  • Terms of Use
  • DMCA
Facebook X (Twitter) Instagram
StreamLineCrypto.comStreamLineCrypto.com
  • Home
  • Crypto News
  • Bitcoin
  • Altcoins
  • NFT
  • Defi
  • Blockchain
  • Metaverse
  • Regulations
  • Trading
StreamLineCrypto.comStreamLineCrypto.com

Propanc Biopharma Secures up to $100 million for Crypto Treasury

November 10, 2025Updated:November 10, 2025No Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Propanc Biopharma Secures up to 0 million for Crypto Treasury
Share
Facebook Twitter LinkedIn Pinterest Email
ad


Australia-based Propanc Biopharma has introduced that it has secured $100 million from a crypto-focused household workplace to launch a crypto treasury — a transfer its CEO described as “transformative” as its most cancers remedy product enters human trials subsequent yr. 

The non-public placement, structured via convertible most well-liked inventory, supplies Propanc with an preliminary $1 million funding and as much as $99 million in follow-on funding over the following 12 months from Hexstone Capital, a household workplace that invests in a number of crypto treasury firms.

The cancer-treating biotech firm said that the proceeds will likely be used to construct a digital asset treasury and speed up the event of its lead most cancers remedy, PRP, which goals to enter first-in-human trials within the second half of 2026.

Propanc CEO James Nathanielsz stated the crypto treasury would help a “transformative section” for the corporate by strengthening its steadiness sheet and advancing its proenzyme-based oncology platform. 

“We are able to goal not solely sufferers affected by metastatic most cancers from stable tumors, however a number of power illnesses primarily based upon the mechanism of motion of proenzyme remedy.”

Whereas Propanc didn’t say which digital property it plans to purchase for its crypto treasury, Hexstone’s shoppers have invested in every little thing from Bitcoin (BTC), Ether (ETH), Solana (SOL), Injective (INJ) in addition to some lesser-known cryptocurrencies.

Biotech firms adopting a crypto technique

Propanc joins Sonnet BioTherapeutics, Sharps Know-how and different biotech firms which have turned to crypto to reignite investor curiosity.